Koji Masuda

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 113 publications

Multicentric Reticulohistiocytosis Progressing to Erythroderma After Long-Term Disease Progression.

Multicentric Reticulohistiocytosis Progressing to Erythroderma After Long-Term Disease Progression.

Journal: The Journal of dermatology

Published: April 15, 2026

Preoperative Questionnaire Evaluation and Testing for Latex Allergy: A Retrospective Study From 2015 to 2021.

Preoperative Questionnaire Evaluation and Testing for Latex Allergy: A Retrospective Study From 2015 to 2021.

Journal: The Journal of dermatology

Published: January 12, 2026

Maintained improvement of outcomes related to skin clearance, itch, sleep and quality of life with baricitinib in adults with moderate-to-severe Atopic Dermatitis who were treated for up to 200 weeks in a randomized trial.

Maintained improvement of outcomes related to skin clearance, itch, sleep and quality of life with baricitinib in adults with moderate-to-severe Atopic Dermatitis who were treated for up to 200 weeks in a randomized trial.

Journal: The Journal of dermatological treatment

Published: November 27, 2025

Three-Year Follow-Up of the PACI Randomized Controlled Trial (PACI-ON): Effects of Early Intervention for Atopic Dermatitis on Atopic March.

Three-Year Follow-Up of the PACI Randomized Controlled Trial (PACI-ON): Effects of Early Intervention for Atopic Dermatitis on Atopic March.

Journal: Allergy

Published: November 14, 2025

Molecular profile of interleukin-17RA blockade by brodalumab in Japanese patients with psoriasis: Results from the ESPRIT study.

Molecular profile of interleukin-17RA blockade by brodalumab in Japanese patients with psoriasis: Results from the ESPRIT study.

Journal: Journal of dermatological science

Published: May 22, 2025

National survey on diagnosis and treatment of adult anaphylaxis in Japan: The learning about anaphylaxis in adolescence and adulthood (LANA) survey Part 1.

National survey on diagnosis and treatment of adult anaphylaxis in Japan: The learning about anaphylaxis in adolescence and adulthood (LANA) survey Part 1.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: April 30, 2025

Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2024.

Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2024.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: December 24, 2024

English version of clinical practice guidelines for the management of atopic dermatitis 2024.

English version of clinical practice guidelines for the management of atopic dermatitis 2024.

Journal: The Journal of dermatology

Published: October 10, 2024

Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR-mutant NSCLC.

Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR-mutant NSCLC.

Journal: ESMO real world data and digital oncology

Published: July 27, 2024

Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study.

Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study.

Journal: Frontiers in immunology

Published: June 03, 2024

Depigmented contact dermatitis due to phenylbenzimidazole sulfonic acid contained in skin lotion.

Depigmented contact dermatitis due to phenylbenzimidazole sulfonic acid contained in skin lotion.

Journal: Contact dermatitis

Published: February 29, 2024

Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis.

Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis.

Journal: The journal of allergy and clinical immunology. Global

Published: January 19, 2024

Showing 1-12 of 113

Last Updated: 09/26/2026